diimine complexes
Recently Published Documents


TOTAL DOCUMENTS

479
(FIVE YEARS 14)

H-INDEX

52
(FIVE YEARS 0)

Author(s):  
Daniele Franchi ◽  
Valentina Leandri ◽  
Angela Raffaella Pia Pizzichetti ◽  
Bo Xu ◽  
Yan Hao ◽  
...  


Author(s):  
Ranjeesh Thenarukandiyil ◽  
Eno Paenurk ◽  
Anthony Wong ◽  
Natalia Fridman ◽  
Amir Karton ◽  
...  




Chemistry ◽  
2021 ◽  
Vol 3 (4) ◽  
pp. 1178-1188
Author(s):  
Bandar A. Babgi ◽  
Doaa Domyati ◽  
Magda H. Abdellattif ◽  
Mostafa A. Hussien

Several metal diimine complexes have been reported to possess anticancer properties. To evaluate the anticancer properties of tetrahedral zinc(II) diimine complexes, six complexes were synthesized with the general formula M(N^N)Cl2 {where M = Zn, Pt and N^N = 2,2’-biquinoline (1), 2,2’-dipyridylketone (2) and 4-((pyridine-2-ylmethylene)amino)phenol (3)}. In general, the intrinsic DNA-binding constants for the different compounds exhibited values within close proximity; the changes in the viscosity of the CT-DNA upon binding to the compounds suggest intercalation-binding mode. Molecular docking study predicted that complexes containing the highly planar ligand 2,2’-biquinoline are capable to establish π–π interactions with nucleobases of the DNA; the other four complexes engaged in donor–acceptor interactions with DNA nucleobases. The six complexes and two reference drugs (cisplatin and sunitinib) were tested against two cancer cell lines (COLO 205 and RCC-PR) and one normal cell line (LLC-MK2), highlighting the better performance of the zinc(II) complexes compared to their platinum(II) analogues. Moreover, zinc(II) complexes have higher selectivity index values than the reference drugs, with promising anticancer properties.



2021 ◽  
pp. 120501
Author(s):  
Tian-Cheng Wu ◽  
Qiao-Long Hu ◽  
Ting-Hong Huang ◽  
Yi-Shun Cui ◽  
Dan Zheng ◽  
...  


Polyhedron ◽  
2021 ◽  
pp. 115168
Author(s):  
Julia A. Brown ◽  
Alexandra L. Chaparro ◽  
Leah C. McCarthy ◽  
Sophia C. Moniodes ◽  
Erin E. Ostrowski ◽  
...  


Crystals ◽  
2021 ◽  
Vol 11 (3) ◽  
pp. 300
Author(s):  
Ahmed Gaber ◽  
Arafa A. M. Belal ◽  
Ibrahim M. El-Deen ◽  
Nader Hassan ◽  
Rozan Zakaria ◽  
...  

Metal-ligand complexes have attracted major interest due to their potential medical applications as anticancer agents. The work described in the current article aimed to synthesize, spectroscopic, thermal, and biological studies of some metal-diimine complexes. A diimine ligand, namely 2-{[2-(4-chlorophenyl)-2-hydroxyvinyl]-hydrazonomethyl}phenol (diim) was prepared via the reaction of p-chlorophenacyl bromide with hydrazine hydrate in ethanol, then condensation was completed with 2-hydroxybenzaldehyde in acetic acid. The Co(II), Ni(II), Cu(II), and Zn(II) complexes were prepared with a metal:ligand stoichiometric ratio of (2:1). 1H-NMR, UV-Vis, FTIR spectroscopic data, molar conductivity measurements, and microanalytical data (carbon, hydrogen, nitrogen, and halogen) were used for characterization of the formed ligand and its metal complexes. It was found that the diimine ligand act as tetradentate fashion. The non-electrolytic character for all the complexes was proved by molar conductivity. The first metal atom of the synthesized binuclear diimine complexes coordinates with the nitrogen of hydrazine group and oxygen of OH group. While, the second metal atom coordinates with the other nitrogen atom of the hydrazine group and oxygen of phenolic group. All the synthesized metal complexes have a six-coordinated except for Zn(II) has four-coordinated. Thermogravimetric analysis and its differential analysis were done to discuss the thermal degradation of the free ligand and its metal complexes. Molecular docking calculation showed that the diimine ligand is a good inhibitor for breast cancer 3hb5 and 4o1v kidney cancer proteins. Additionally, these compounds were evaluated as antibacterial and antifungal agents.



Sign in / Sign up

Export Citation Format

Share Document